At EgSCRS, ELZA’s pyramid approach to keratoconus: ELZA-sub400, PACE, ECO-CAIRS, and AI-guided diagnostics was presented in detail.
ELZA-PACE combines epi-on cross-linking with customized PTK for keratoconus without stromal tissue removal – as reported by Ocular Surgery News
In a recent feature, Ocular Surgery News (OSN) provided an in-depth overview of the latest advancements in epi-on crosslinking, as presented by Prof. Farhad Hafezi of the ELZA Institute at the Winter ESCRS meeting in Frankfurt, Germany.
Epi-On Cross-Linking goes office-based! ELZA’s innovation eliminates bulky equipment, offering streamlined keratoconus care, tells Farhad Hafezi to Ocular Surgery News.
A significant part of the symposium was dedicated to showcasing collaborative initiatives between Switzerland and Uzbekistan, particularly in healthcare. One example was a keratoconus screening initiative led by Ms. Nikki Hafezi, ELZA’s CEO, and a graduate of ETH Zürich and the University of Bern. This project, undertaken with local NGOs, provided vision screenings to 117 families, identifying three children with keratoconus. These children received further medical consultations and guidance for managing the condition.
Prof. Farhad Hafezi from the ELZA Institute provided an insightful update on the Second Global Consensus on Keratoconus during an interview with EyeTube.
Prof. Hafezi presents Femto-CAIRS and high fluence cross-linking, highlighting its advantages for keratoconus treatment and improving visual outcomes
Dr. Dr. Torres-Netto explained to OSN how ELZA-STARK addresses astigmatism in patients with a history of radial keratotomy (RK).
Professor Farhad Hafezi from the ELZA Institute has prepared a presentation that provides a comprehensive overview of how oxygen concentration is at the center of all these decisions. CXL and oxygen is at the center of everything to do with the UV-riboflavin cross-linking reaction
At the ELZA Institute in Zurich, Switzerland, we developed the sub400 protocol to treat extremely thin corneas.
